{"id":1031,"date":"2022-09-28T01:41:45","date_gmt":"2022-09-28T01:41:45","guid":{"rendered":"https:\/\/sites.chapman.edu\/cilia\/?page_id=1031"},"modified":"2026-01-06T18:47:24","modified_gmt":"2026-01-06T18:47:24","slug":"muhammad-imran-sajid","status":"publish","type":"page","link":"https:\/\/sites.chapman.edu\/cilia\/muhammad-imran-sajid\/","title":{"rendered":"Muhammad Imran Sajid"},"content":{"rendered":"<p><a href=\"https:\/\/sites.chapman.edu\/cilia\/wp-content\/uploads\/sites\/30\/2022\/12\/Profile-Photo-for-Celia.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-1115\" src=\"https:\/\/sites.chapman.edu\/cilia\/cilia\/files\/2022\/12\/Profile-Photo-for-Celia-248x300.jpg\" alt=\"\" width=\"248\" height=\"300\" srcset=\"https:\/\/sites.chapman.edu\/cilia\/wp-content\/uploads\/sites\/30\/2022\/12\/Profile-Photo-for-Celia-248x300.jpg 248w, https:\/\/sites.chapman.edu\/cilia\/wp-content\/uploads\/sites\/30\/2022\/12\/Profile-Photo-for-Celia.jpg 517w\" sizes=\"auto, (max-width: 248px) 100vw, 248px\" \/><\/a><\/p>\n<p>&nbsp;<\/p>\n<h4><strong>CONTACT<\/strong><\/h4>\n<h4>Muhammad Imran Sajid, Pharm.D, Ph.D (Fulbright Fellow)<\/h4>\n<div>Postdoctoral Research Associate<\/div>\n<div>School of Pharmacy, Chapman University<\/div>\n<div>Harry and Diane Rinker Health Science Campus<\/div>\n<div>9401 Jeronimo Road, Irvine, CA 92618, USA<\/div>\n<div>Mob: +1-949-993-6348<\/div>\n<div>Office: +1-714-516-5447<\/div>\n<div>Email:\u00a0<a href=\"mailto:ayankumarbarui@gmail.com\">masajid@chapman.edu<\/a><\/div>\n<p><a href=\"https:\/\/www.linkedin.com\/in\/muhammad-imran-sajid-ph-d-pharm-d-m-phil-27b92322\/\">LinkedIn<\/a>\u00a0|\u00a0<a href=\"https:\/\/scholar.google.com\/citations?user=nlFgTeAAAAAJ&amp;hl=en\">Google Scholar<\/a><\/p>\n<h3>BIOGRAPHY<\/h3>\n<p>Muhammad Imran Sajid is a self-motivated pharmacist, scientist and teacher with more than a decade of university teaching experience. He was promoted to Associate Professor in Pharmaceutical Sciences at University of Central Punjab, Lahore, Pakistan in July 2022 after earning his Ph.D on the prestigious Fulbright Scholarship from Chapman University School of Pharmacy. He has more than 17 peer-reviewed papers with an impact factor exceeding 82 and a ball park of 500 citations. He likes to work in win-win situations and is always eager to contribute novel executable ideas. Innovation and thriving for excellence are his passions.<\/p>\n<p>Currently, he is working on siRNA delivery systems to treat fibrosis. Also, he is investigating the role of celia in neurodegenerative diseases. He is inspired by the work of Ray Kurzweil, Peter Diamandis and Yuval Noah Harari, who believe in exciting new future where the sciece is striving for longetivity, happiness and a quality of life.<\/p>\n<p><strong>EDUCATION AND QUALIFICATION:<\/strong><\/p>\n<p><strong>Ph.D. Pharmaceutical Sciences (2018-2022)<\/strong><\/p>\n<p>Chapman University School of Pharmacy, Irvine, CA, USA<\/p>\n<p><strong>Foreign Pharmacy Graduate Equivalency Committee (FPGEC) Certificate<\/strong> (<strong>2016)<\/strong><strong> \u00a0\u00a0\u00a0<\/strong><\/p>\n<p>National Association of Boards of Pharmacy, USA <strong>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0<\/strong><\/p>\n<p><strong>M.Phil. Pharmaceutics (2016)<\/strong><\/p>\n<p>University of Central Punjab, Lahore, Pakistan<\/p>\n<p><strong>M.Phil. Biochemistry (2010)<\/strong><\/p>\n<p>King Edward Medical University, Lahore, Pakistan<\/p>\n<p><strong>Doctor of Pharmacy (Pharm.D) (2008)<\/strong><\/p>\n<p>The University College of Pharmacy, University of the Punjab, Lahore, Pakistan<\/p>\n<p><strong>HONORS AND AWARDS<\/strong><\/p>\n<ul>\n<li>The Prestigious Fulbright Scholarship award for doing Ph.D. in Pharmaceutical Sciences from Chapman University, California, USA. The scholarship was awarded for four years (2018-2022) worth US $ 250,000\/-<\/li>\n<li>Award of Stipend under M.Phil. Biochemistry Program on the recommendation of Scholarship Committee at King Edward Medical University, Lahore, Pakistan. The Stipend was awarded for two years (2009-2010) worth Pak Rupees 540,000\/-<\/li>\n<li>Registered as Pharmacist in category A in the Punjab Pharmacy Council, Lahore, Pakistan<\/li>\n<li>Member Board of Studies, University of Central Punjab, Pakistan<\/li>\n<li>Member of Pakistan Pharmacist Association (PPA) Lahore, Pakistan<\/li>\n<li>Executive Member UCP health club<\/li>\n<li>Awarded a grant of Rs 300,000\/- for M.Phil. project from King Edward Medical University<\/li>\n<\/ul>\n<p><strong>SCIENTIFIC PUBLICATIONS:<\/strong><\/p>\n<ol>\n<li><strong>Muhammad Imran Sajid<\/strong>, Dindyal Mandal, Nagla Salem El-Sayed, Sandeep Lohan, Jonathan Moreno, and Rakesh Kumar Tiwari, <em>\u201c<u>Oleyl conjugated Histidine-Arginine cell-penetrating peptides as promising agents for siRNA delivery<\/u>\u201d,<\/em> Pharmaceutics,<strong> 2022<\/strong> 14(4), 881 <strong>Impact Factor: 6.525<\/strong><\/li>\n<\/ol>\n<p><a href=\"https:\/\/doi.org\/10.3390\/pharmaceutics14040881\">https:\/\/doi.org\/10.3390\/pharmaceutics14040881<\/a><\/p>\n<ol start=\"2\">\n<li><strong>Muhammad Imran Sajid<\/strong>, Sandeep Lohan, Shun Kato, Rakesh Kumar Tiwari, \u201c<em><u>Combination of Amphiphilic Cyclic Peptide [R4W4] and Levofloxacin Against Multidrug-Resistant Bacteria<\/u>\u201d<\/em>, Antibiotics,<strong> 2022<\/strong> 11(3), 416<strong> Impact Factor 5.396<\/strong><\/li>\n<\/ol>\n<p><a href=\"https:\/\/doi.org\/10.3390\/antibiotics11030416\">https:\/\/doi.org\/10.3390\/antibiotics11030416<\/a><\/p>\n<ol start=\"3\">\n<li>Naglaa Salem El-Sayed, <strong>Muhammad Imran Sajid,<\/strong> Keykavous Parang, Rakesh Kumar Tiwari, \u201c<em><u>Synthesis, characterization, and cytotoxicity evaluation of dextran-myristoyl-ECGKRK peptide conjugate<\/u>\u201d<\/em>, International Journal of Biological Macromolecules,<strong> 2022<\/strong> 191 (2021) 1204\u2013121 <strong>Impact Factor:8.025<\/strong><\/li>\n<\/ol>\n<p><a href=\"https:\/\/doi.org\/10.1016\/j.ijbiomac.2021.09.160\">https:\/\/doi.org\/10.1016\/j.ijbiomac.2021.09.160<\/a><\/p>\n<ol start=\"4\">\n<li>Amir Nasrolahi Shirazi, <strong>Muhammad Imran Sajid<\/strong>, Dindyal Mandal, David Stickley, Stephanie Nagasawa, Joshua Long, Sandeep Lohan, Keykavous Parang, and Rakesh Kumar Tiwari, &#8220;<em><u>Cyclic Peptide-Gadolinium Nanocomplexes as siRNA Delivery Tools<\/u>\u201d,<\/em> Pharmaceuticals,<strong> 2022<\/strong> 14(11), 1064 <strong>Impact Factor:5.677<\/strong><\/li>\n<\/ol>\n<p><a href=\"https:\/\/doi.org\/10.3390\/ph14111064\">https:\/\/doi.org\/10.3390\/ph14111064<\/a><\/p>\n<ol start=\"5\">\n<li>Sorour Khayyatnejad Shoushtari, Khalid Zoghebi, <strong>Muhammad Imran Sajid<\/strong>, Rakesh Kumar Tiwari, and Keykavous Parang, &#8220;<em><u>Hybrid Cyclic-Linear Cell-Penetrating Peptides Containing Alternative Positively Charged and Hydrophobic Residues as Molecular Transporters<\/u><\/em>\u201d, Molecular Pharmaceutics,\u00a0<strong>2021 <\/strong><em>18<\/em>(10), 3909-3919 <strong>Impact Factor: 5.364<\/strong><\/li>\n<\/ol>\n<p><a href=\"https:\/\/doi.org\/10.1021\/acs.molpharmaceut.1c00594\">https:\/\/doi.org\/10.1021\/acs.molpharmaceut.1c00594<\/a><\/p>\n<ol start=\"6\">\n<li>Shang Eun Park, Naglaa Salem El-Sayed, Kiumars Shamloo, Sandeep Lohan, Sumit Kumar, <strong>Muhammad Imran Sajid<\/strong>, Rakesh Kumar Tiwari, \u201c<em><u>Targeted Delivery of Cabazitaxel Using Cyclic Cell-Penetrating Peptide and Biomarkers of Extracellular Matrix for Prostate and Breast Cancer Therapy<\/u>\u201d<\/em>, Bioconjugate Chemistry,<strong> 2021<\/strong> 32(8), 1898-1914 <strong>Impact Factor: 6.069<\/strong><\/li>\n<\/ol>\n<p><a href=\"https:\/\/doi.org\/10.1021\/acs.bioconjchem.1c00319\">https:\/\/doi.org\/10.1021\/acs.bioconjchem.1c00319<\/a><\/p>\n<ol start=\"7\">\n<li><strong>Muhammad Imran Sajid<\/strong>, Muhammad Moazzam, Yeseom Cho, Shun Kato, Ava Xu, JJ Way, Sandeep Lohan, Rakesh K Tiwari, \u201c<em><u>siRNA Therapeutics for the Therapy of COVID-19 and Other Coronaviruses<\/u>\u201d<\/em>, Molecular Pharmaceutics,<strong> 2021<\/strong> 18(6), 2105-2121 <strong>Impact Factor: 5.364<\/strong><\/li>\n<\/ol>\n<p><a href=\"https:\/\/doi.org\/10.1021\/acs.molpharmaceut.0c01239\">https:\/\/doi.org\/10.1021\/acs.molpharmaceut.0c01239<\/a><\/p>\n<ol start=\"8\">\n<li><strong>Muhammad Imran Sajid<\/strong>, Muhammad Moazzam, Ryan Steuber, Shang Eun Park, Yeseom Cho, Rakesh K Tiwari, \u201c<em><u>Applications of amphipathic and cationic cyclic cell-penetrating peptides: Significant therapeutic delivery tool<\/u>\u201d<\/em>, Peptides, <strong>2021 <\/strong>141, 170542 <strong>Impact Factor: 3.867<\/strong><\/li>\n<\/ol>\n<p><a href=\"https:\/\/doi.org\/10.1016\/j.peptides.2021.170542\">https:\/\/doi.org\/10.1016\/j.peptides.2021.170542<\/a><\/p>\n<ol start=\"9\">\n<li><strong>Muhammad Imran Sajid, <\/strong>Muhammad Moazzam, Shun Kato, Kayley Yeseom Cho, Rakesh Kumar Tiwari, \u201c<em><u>Overcoming barriers for siRNA therapeutics: From bench to bedside<\/u>\u201d<\/em>, Pharmaceuticals, <strong>2020<\/strong> 13(10), 294 <strong>Impact Factor: 5.677<\/strong><\/li>\n<\/ol>\n<p><a href=\"https:\/\/doi.org\/10.3390\/ph13100294\">https:\/\/doi.org\/10.3390\/ph13100294<\/a><\/p>\n<ol start=\"10\">\n<li>Amir Nasrolahi Shirazi, Shang Eun Park, Shirin Rad, Luiza Baloyan, Dindyal Mandal, <strong>Muhammad Imran Sajid<\/strong>, Ryley Hall, Sandeep Lohan, Khalid Zoghebi, Keykavous Parang, Rakesh Kumar Tiwari, \u201c<em><u>Cyclic Peptide-Gadolinium Nanoparticles for Enhanced Intracellular Delivery<\/u>\u201d<\/em>, Pharmaceutics, <strong>2020 <\/strong>12(9), 792 <strong>Impact Factor: 6.525<\/strong><\/li>\n<\/ol>\n<p><a href=\"https:\/\/doi.org\/10.3390\/pharmaceutics12090792\">https:\/\/doi.org\/10.3390\/pharmaceutics12090792<\/a><\/p>\n<ol start=\"11\">\n<li>Muhammad Moazzam, <strong>Muhammad Imran Sajid<\/strong>, Hamza Shahid, Jahanzaib Butt, Irfan Bashir, Muhammad Jamshaid, Amir Nasrolahi Shirazi, Rakesh Kumar Tiwari, \u201c<em><u>Understanding COVID-19: from origin to potential therapeutics<\/u>\u201d, <\/em>International Journal of Environmental Research and Public Health,<strong> 2020<\/strong> 17(16), 5904 <strong>Impact Factor: 4.614<\/strong><\/li>\n<\/ol>\n<p><a href=\"https:\/\/doi.org\/10.3390\/ijerph17165904\">https:\/\/doi.org\/10.3390\/ijerph17165904<\/a><\/p>\n<ol start=\"12\">\n<li>Shang Eun Park, <strong>Muhammad Imran Sajid<\/strong>, Keykavous Parang, Rakesh Kumar Tiwari, \u201c<em><u>Cyclic cell-penetrating peptides as efficient intracellular drug delivery tools<\/u>\u201d<\/em>, Molecular Pharmaceutics,<strong> 2019<\/strong> 16(9), 3727-3743 <strong>Impact Factor: 5.364<\/strong><\/li>\n<\/ol>\n<p><a href=\"https:\/\/doi.org\/10.1021\/acs.molpharmaceut.9b00633\">https:\/\/doi.org\/10.1021\/acs.molpharmaceut.9b00633<\/a><\/p>\n<ol start=\"13\">\n<li>Naglaa Salem El-Sayed, Amir Nasrolahi Shirazi, <strong>Muhammad Imran Sajid<\/strong>, Shang Eun Park, Keykavous Parang, Rakesh Kumar Tiwari, \u201c<em><u>Synthesis and antiproliferative activities of conjugates of paclitaxel and camptothecin with a cyclic cell-penetrating peptide<\/u>\u201d<\/em>, Molecules,<strong> 2019<\/strong> 24(7), 1427 <strong>Impact Factor: <em>4.927<\/em><\/strong><\/li>\n<\/ol>\n<p><a href=\"https:\/\/doi.org\/10.3390\/molecules24071427\">https:\/\/doi.org\/10.3390\/molecules24071427<\/a><\/p>\n<ol start=\"14\">\n<li>Faheem Ahmed Siddiqui, Mansoor Ahmad, Noor Jahan, and <strong>Muhammad Imran Sajid<\/strong>, &#8220;<em>Phytochemical screening and assessment of analgesic, Anti-inflammatory and hematological properties of the fruit of Berberis baluchistanica<\/em>.&#8221; Pakistan Journal of Pharmaceutical Sciences 30 (2017). <strong>Impact Factor 0.684<\/strong><\/li>\n<\/ol>\n<p><a href=\"https:\/\/applications.emro.who.int\/imemrf\/Pak_J_Pharm_Sci\/Pak_J_Pharm_Sci_2017_supp_3_1007_1012.pdf\">https:\/\/applications.emro.who.int\/imemrf\/Pak_J_Pharm_Sci\/Pak_J_Pharm_Sci_2017_supp_3_1007_1012.pdf<\/a><\/p>\n<ol start=\"15\">\n<li><strong>Muhammad Imran Sajid<\/strong>, Usama Jamshaid, Talha Jamshaid, Nadiah Zafar, H. Fessi, and Abdelhamid Elaissari. &#8220;Carbon nanotubes from synthesis to in vivo biomedical applications.&#8221;\u00a0<em>International journal of pharmaceutics <\/em>501, no. 1-2 (2016): 278-299. <strong>Impact Factor 6.510<\/strong><\/li>\n<\/ol>\n<p><a href=\"https:\/\/doi.org\/10.1016\/j.ijpharm.2016.01.064\">https:\/\/doi.org\/10.1016\/j.ijpharm.2016.01.064<\/a><\/p>\n<ol start=\"16\">\n<li>Syed Amjad Ali Raza, <strong>Muhammad Imran Sajid<\/strong>, Usama Jamshaid, Talha Jamshaid, Rabia Aslam, Akhlaq Ahmed, Sarah Shigdar, and Muhammad Jamshaid<em><u>. &#8220;Ethosomes the Best Approach for Deeper Delivery of Drugs through Transdermal Port: From Preparation to Biomedical Applications.&#8221;<\/u><\/em> Journal of Colloid Science and Biotechnology 4, no. 2 (2015): 87-98. <strong>Impact Factor: N\/A<\/strong><\/li>\n<\/ol>\n<p><a href=\"https:\/\/doi.org\/10.1166\/jcsb.2015.1121\">https:\/\/doi.org\/10.1166\/jcsb.2015.1121<\/a><\/p>\n<ol start=\"17\">\n<li>Ghulam Jilany Khan, Hafiza Sadaf Naeem, Sara Khan, Talha Jamshaid, <strong>Muhammad Imran Sajid<\/strong>, Irfan Bashir, and Muhammad Jamshaid. &#8220;<em><u>Understanding and responsiveness level about cervical cancer and its avoidance among young women of Pakistan<\/u><\/em>.&#8221; Asian Pacific Journal of Cancer Prevention 15, no. 12 (2014): 4877-4883. <strong>Impact Factor: 1.77<\/strong><\/li>\n<\/ol>\n<p><a href=\"http:\/\/dx.doi.org\/10.7314\/APJCP.2014.15.12.4877\">http:\/\/dx.doi.org\/10.7314\/APJCP.2014.15.12.4877<\/a><\/p>\n<ol start=\"18\">\n<li>Ghulam Jilany Khan, Fareeha Khaliq Khan, Rizwan Ahmad Khan, Muhammad Jamshaid, Fauzia Tajdin, and Muhammad Imran Sajid. &#8220;Alternative Medicine;The Tendency Of Using Complimentary Alternative Medicine In Patients Of Different Hospitals Of Lahore, Pakistan.&#8221; The Professional Medical Journal 21, no. 06 (2014): 1178-1184. <strong>Impact Factor: N\/A<\/strong><\/li>\n<\/ol>\n<p><a href=\"https:\/\/doi.org\/10.29309\/TPMJ\/2014.21.06.2260\">https:\/\/doi.org\/10.29309\/TPMJ\/2014.21.06.2260<\/a><\/p>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>&nbsp; CONTACT Muhammad Imran Sajid, Pharm.D, Ph.D (Fulbright Fellow) Postdoctoral Research Associate School of Pharmacy, Chapman University Harry and Diane Rinker Health Science Campus 9401 Jeronimo Road, Irvine, CA 92618, USA Mob: +1-949-993-6348 Office: +1-714-516-5447 Email:\u00a0masajid@chapman.edu LinkedIn\u00a0|\u00a0Google Scholar BIOGRAPHY Muhammad &hellip; <a href=\"https:\/\/sites.chapman.edu\/cilia\/muhammad-imran-sajid\/\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":63,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-1031","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/sites.chapman.edu\/cilia\/wp-json\/wp\/v2\/pages\/1031","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/sites.chapman.edu\/cilia\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/sites.chapman.edu\/cilia\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/sites.chapman.edu\/cilia\/wp-json\/wp\/v2\/users\/63"}],"replies":[{"embeddable":true,"href":"https:\/\/sites.chapman.edu\/cilia\/wp-json\/wp\/v2\/comments?post=1031"}],"version-history":[{"count":0,"href":"https:\/\/sites.chapman.edu\/cilia\/wp-json\/wp\/v2\/pages\/1031\/revisions"}],"wp:attachment":[{"href":"https:\/\/sites.chapman.edu\/cilia\/wp-json\/wp\/v2\/media?parent=1031"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}